White label ELPA - ClinicalTrials.eu

ICP-332 for Adults with Prurigo Nodularis

Recruiting

2 1
Study on Brimonidine Eye Drops to Prevent Myopia Progression in Children Aged 6 to 14 Years

Recruiting

2 1 1 1
Investigated Drugs:
- Brimonidine Tartrate
A Phase I/II Study of GVV858 Alone or in Drug Combination for Patients with Advanced Hormone Receptor‑Positive, HER2‑Negative Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
- Neoplasm malignant
Investigated Drugs:
Study of Vosoritide Safety and Effectiveness in Infants and Young Children (0 to 36 months) with Hypochondroplasia

Recruiting

2 1 1
Investigated Diseases:
- Hypochondroplasia
Investigated Drugs:
- Vosoritide
BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus

Recruiting

2 1

+1
Long-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials

Recruiting

3 1 1
Investigated Diseases:
- IgA nephropathy
Investigated Drugs:
- ZIGAKIBART
+2
Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Recruiting

3 1 1
Investigated Diseases:
- Migraine
Investigated Drugs:
- Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
+3
A study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.

Recruiting

3 1 1
Investigated Drugs:
- Lidocaine Hydrochloride
A study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy

Recruiting

3 1 1
Investigated Diseases:
- Ductal adenocarcinoma of pancreas
Investigated Drugs:
- (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
A Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment

Recruiting

4 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies